IL10 and type 2 diabetes mellitus: PZA and INH treatment to the in vitro granulomas generated from T2DM subjects at 3-months post- L-GSH treatment also resulted in a significant 3-fold decrease in the levels of IL-10 when compared the untreated (control) category before L-GSH supplementation (Figure 7B).